Complications associated with the use of oral anticoagulation in patients with pulmonary arterial hypertension from two referral centers

Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial

(2016) Markus Messerli et al.   BMC HEALTH SERVICES RESEARCH

Antithrombotic Therapy for VTE Disease

(2016) Clive Kearon et al.   CHEST

Deep vein thrombosis and pulmonary embolism

(2016) Marcello Di Nisio et al.   LANCET

Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension

(2016) Laurence Gabriel et al.   RESPIRATION

Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)CLINICAL PERSPECTIVE

(2015) Ioana R. Preston et al.   CIRCULATION

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

(2015) N. S. Abraham et al.   BMJ-British Medical Journal

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study

(2015) N. S. Abraham et al.   BMJ-British Medical Journal

Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort

(2013) Vicky Tagalakis et al.   AMERICAN JOURNAL OF MEDICINE

Anticoagulation and Survival in Pulmonary Arterial Hypertension

(2013) Karen M. Olsson et al.   CIRCULATION

Definitions and Diagnosis of Pulmonary Hypertension

(2013) Marius M. Hoeper et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Assessing bleeding risk in patients taking anticoagulants

(2013) Marwa Shoeb et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation

(2012) Leif Friberg et al.   CIRCULATION

Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension

(2012) Ivo R. Henkens et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical implications of haemoptysis in patients with pulmonary arterial hypertension

(2012) Jose Cantu et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Minor bleeds alert for subsequent major bleeding in patients using vitamin K antagonists

(2011) Nic J. G. M. Veeger et al.   BRITISH JOURNAL OF HAEMATOLOGY

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA

(2011) M. Wieloch et al.   EUROPEAN HEART JOURNAL

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Venous Thromboembolism

(2010) Michele G. Beckman et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Bleeding events in pulmonary arterial hypertension

(2009) C. F. Opitz et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE